NCT05974696 A Research Registry on Aggressive PitNETs
| NCT ID | NCT05974696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Endocrine Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-06-15 |
| Primary Completion | 2029-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-06-15 with a primary completion date of 2029-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To allow the identification of markers, it is necessary to extend research networks more widely to collect and properly explore aggressive pituitary tumours. The multidisciplinary consultation meeting (RCP), organised by the reference centre for rare diseases of the pituitary gland, dedicated to aggressive pituitary tumours and carcinomas (HYPOcare), which is unique in France and brings together national experts, currently makes it possible to orientate the management of patients with an aggressive pituitary tumour. With more than 80 patient files discussed since its inception, the patient cohort via the HYPOcare RCP is one of the largest both nationally and internationally. At present, this data source is only dedicated to the clinical management of the files without the possibility of carrying out research work
Eligibility Criteria
* Inclusion Criteria : * Patients with a diagnosis of pituitary tumour * Patients whose file has been presented to the national HYPOcare RCP * Exclusion Criteria : * Patients objecting to participating in this research
Frequently Asked Questions
Who can join the NCT05974696 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Endocrine Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05974696 currently recruiting?
Yes, NCT05974696 is actively recruiting participants. Visit ClinicalTrials.gov or contact Hospices Civils de Lyon to inquire about joining.
Where is the NCT05974696 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT05974696 clinical trial?
NCT05974696 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 200 participants.